3D artificial heart tissue
Commonly used acronym: Heart Patch
Scope of the method
- Human health
- Basic Research
- Translational - Applied Research
- In vitro - Ex vivo
- Human derived cells / tissues / organs
Description
- heart model
- 3D
- Human induced Pluripotent Stem Cell
- multi electrode array
- plasma treatment
- cell biology
- Cardiology
- cardiac function
- Cardiac electrophysiology
Current pre-clinical drug safety evaluation methods remain costly, inefficient, and unreliable, with 80–90% of compounds ultimately failing in human trials — often due to poor predictive models and safety concerns. Scaffold-based 3D organ models offer a more promising and physiologically relevant alternative in pre-clinical drug testing. We aim to advance this field by optimizing a 3D artificial heart tissue model seeded with key human cell types—cardiomyocytes, fibroblasts, and endothelial cells. This model of heart patch surpasses current 3D cardiac constructs by incorporating bioinspired scaffolds and electro-mechanical stimulation to enhance cell differentiation and tissue maturity. By leveraging human induced pluripotent stem cells (iPSCs), our platform offers a more predictive and human-relevant system for cardiac drug safety and efficacy assessment, helping reduce reliance on in vivo animal testing.
- Still in development
Contact person
Jolanda van HengelOrganisations
Ghent University (UGent)Faculty of Medicine and Health Sciences
Medical Cell Biology research group
Belgium
Flemish Region
Ghent University (UGent)
Research Unit Plasma Technology
Belgium
Flemish Region
Ghent University (UGent)
Cell Physiology and electrophysiology
Belgium
Flemish Region
Ghent University hospital (UZ Gent)
Experimental cardiac surgery-cardiocirculatory physiology
Belgium
Flemish Region
Interuniversitair Micro-Electronica Centrum (IMEC)
Center for Microsystems Technology
Belgium
Flemish Region
University of Hasselt (UHasselt)
Lab of Cardiovascular Physiology
Belgium
Flemish Region